Mogrify Ltd (Mogrify®), a UK company aiming to transform the development of cell therapies by the systematic discovery of novel cell conversions, and Sangamo Therapeutics, a genomic medicine company, today announced that they have executed a collaboration and exclusive licence agreement for Sangamo to develop allogeneic cell therapies from Mogrify’s proprietary induced pluripotent stem cells (...
Mogrify will transform the development of life saving cell therapies via the licence of proprietary cell conversions tailored to any therapeutic application
Telephone: 01223 734154
25 Cambridge Science Park Milton Rd Cambridge
Post Code: CB4 0FW
Country: United Kingdom
Membership Type: Corporate 51+